Brandes Investment Partners’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-283,917	Closed	-$12M	–	194
2024 Q1	$12M	Sell	283,917 -191,824	-40%	-$8.08M	0.15%	102
2023 Q4	$19.9M	Buy	475,741 +3,253	+0.7%	+$120K	0.3%	86
2023 Q3	$17.8M	Sell	472,488 -411	-0.1%	-$15.4K	0.35%	76
2023 Q2	$17.9M	Buy	472,899 +10,543	+2%	+$331K	0.36%	74
2023 Q1	$11.2M	Buy	462,356 +48,811	+12%	+$1.42M	0.24%	90
2022 Q4	$12M	Sell	413,545 -7,037	-2%	-$209K	0.34%	61
2022 Q3	$12.6M	Buy	420,582 +4,593	+1%	+$158K	0.33%	75
2022 Q2	$15M	Buy	415,989 +36,667	+10%	+$1.4M	0.37%	71
2022 Q1	$16.4M	Buy	379,322 +29,606	+8%	+$1.38M	0.35%	76
2021 Q4	$17.5M	Buy	349,716 +83,156	+31%	+$4.66M	0.38%	71
2021 Q3	$17M	Buy	266,560 +12,200	+5%	+$844K	0.37%	71
2021 Q2	$18.3M	Sell	254,360 -151,114	-37%	-$11.1M	0.41%	62
2021 Q1	$30.3M	Sell	405,474 -6,736	-2%	-$511K	0.72%	47
2020 Q4	$29.8M	Buy	412,210 +70,444	+21%	+$4.53M	0.77%	48
2020 Q3	$18.7M	Buy	341,766 +16,824	+5%	+$1.05M	0.65%	50
2020 Q2	$21.6M	Buy	324,942 +68,287	+27%	+$4.58M	0.66%	54
2020 Q1	$15.7M	Buy	256,655 +176,713	+221%	+$13.1M	0.55%	59
2019 Q4	$7.03M	Buy	79,942 +24,877	+45%	+$2.1M	0.17%	83
2019 Q3	$5.47M	Sell	55,065 -840	-2%	-$68.2K	0.14%	84
2019 Q2	$6.26M	Sell	55,905 -9,359	-14%	-$926K	0.14%	85
2019 Q1	$9.27M	Sell	65,264 -3,253	-5%	-$324K	0.22%	76
2018 Q4	$7.94M	Buy	68,517 +23,666	+53%	+$2.28M	0.2%	75
2018 Q3	$6.58M	Buy	44,851 +930	+2%	+$101K	0.15%	85
2018 Q2	$7.64M	Sell	43,921 -16,133	-27%	-$1.77M	0.17%	81
2018 Q1	$5.93M	Sell	60,054 -11,109	-16%	-$1.13M	0.13%	87
2017 Q4	$7.45M	Buy	71,163 +49,327	+226%	+$5.42M	0.15%	84
2017 Q3	$2.46M	Buy	+21,836	New	+$2.38M	0.05%	111